Work

High expression and persistent activation of STAT1, 3 and 5 predicts resistance to the histone deacetylase (HDAC) inhibitor vorinostat (suberoylanilide hydroxamic acid, SAHA) in cutaneous T cell lymphoma cells.

Year: 2007

Type: article

Source: Cancer Research

Authors: Valeria R. Fantin, Andrey Loboda, Jennifer A. Roth, Cloud P. Paweletz, Sophia Randolph, James C.H. Hardwick, Jacqueline W. Pierce, Elizabeth A. Harrington, Ronald C. Hendrickson, John F. Reilly, Christopher Ware, Marshall E. Kadin, Madeleine Duvic, Stanley Frankel, Victoria M. Richon

Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)

Language: English

Topic: Cutaneous lymphoproliferative disorders research

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2739270481

FWCI:

Cites:

Cited by:

Related to: 10